Journal of the American Academy of Child and Adolescent Psychiatry

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Journal of the American Academy of Child and Adolescent Psychiatry  
The Journal of the American Academy of Child and Adolescent Psychiatry.gif
Abbreviated title (ISO 4)
J. Am. Acad. Child Adolesc. Psychiatry
Discipline Pediatric psychiatry
Language English
Edited by Andrés Martin, James J. Hudziak
Publication details
Publisher
Publication history
1987-present
Frequency Monthly
6.354
Indexing
ISSN 0890-8567 (print)
1527-5418 (web)
LCCN 87640752
CODEN JAAPEE
OCLC no. 14404226
Links

The Journal of the American Academy of Child and Adolescent Psychiatry is a peer-reviewed medical journal covering pediatric psychiatry. It is published by Elsevier and is the official journal of the American Academy of Child and Adolescent Psychiatry. The editors-in-chief are Andrés Martin and James J. Hudziak.

According to the Journal Citation Reports, its 2013 impact factor is 6.354, ranking it first among 117 journals in the category "Pediatrics".[1] It is abstracted and indexed in MEDLINE/PubMed, and Science Citation Index.

Concerns About Scientific Misconduct and Fraud[edit]

The group Healthy Skepticism has accused the journal of publishing an article that misrepresented the results of an industry-sponsored clinical trial. Reporting on Study 329 sponsored by then SmithKline Beecham (now GlaxoSmithKline) Keller et al (2001) [2] concluded that paxoxetine was “generally well tolerated and effective" but study 329 was, in fact, negative for efficacy and positive for harm [3] . Healthy Skepticism called upon the editor to retract this article, but to date he has refused to acknowledge fraud or to retract. According to Healthy Skepticism, this raises questions about other industry-sponsored clinical trials reported in the journal and the editor's commitment to enforcing the journal's conflict of interest policy.

References[edit]

  1. ^ "Journals Ranked by Impact: Pediatrics". 2013 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2014. 
  2. ^ M. B. Keller, N. D. Ryan, M. Strober, R. G. Klein, S. P. Kutcher, B. Birmaher, O. R. Hagino, H. Koplewicz, G. A. Carlson, G. N. Clarke, G. J. Emslie, D. Feinberg, B. Geller, V. Kusumakar, G. Papatheodorou, W. H. Sack, M. Sweeney, K. D. Wagner, E. B. Weller, N. C. Winters, R. Oakes and J. P. McCafferty. (2001). Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762-72. doi
  3. ^ Jureidini, J., McHenry, L, and Mansfield, P. “Clinical Trials and Drug Promotion: Selective Reporting of Study 329, International Journal of Risk & Safety in Medicine, (2008); McHenry, L. and Jureidini, J. “Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study,” Accountability in Research, (2008)

External links[edit]